Overview

Management strategies for cardiovascular risk in patients with type 2 diabetes mellitus (T2DM) are rapidly evolving as cardiovascular outcome trial (CVOT) data with newer glucose-lowering therapies continues to emerge, presenting new opportunities for members of the healthcare team to improve care for patients with T2DM. The goal of this educational activity is to provide nurse practitioners and physician assistants with updates on new and emerging CVOT data for glucose lowering therapies, assess clinical implications of CVOT results on real-world T2DM treatment selection, review updated ADA/AACE guidelines for the management of T2DM, and explore effective strategies to individualize T2DM therapy and reduce cardiovascular risk. This interactive symposium will use case studies and audience response, to help participants develop effective strategies to optimize the management of T2DM and CVD and cardiovascular disease.

Speakers

Kathryn Kreider, DNP, FNP-BC, BC-ADM

Assistant Professor, Duke University School of Nursing
Lead Faculty, Endocrinology Specialty
Nurse Practitioner and Director for Advanced Practice Providers
Division of Endocrinology, Metabolism, and Nutrition
Duke University Medical Center
Durham, North Carolina
View Full Bio

Michael Clark, PhD, PA-C, MPAS, AACC, DFAAPA

General/Preventive Cardiology
Adjunct Clinical Associate Professor
Touro College School of Health Sciences
Heart Center of North Texas
Weatherford, Texas
View Full Bio

Accreditation

AAPA

CEC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 hour AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

AANP

This activity is approved for 1.00 contact hour of continuing education by the American Association of Nurse Practitioners. Pharmacologic hours; .75

This activity was planned in accordance with AANP Accreditation Standards and Policies.

Other

Creative Educational Concepts, Inc. certifies this activity for 1.00 hour of participation.

Acknowledgement

Presented by Creative Educational Concepts, Inc. (CEC) and supported through an independent educational grant from AstraZeneca.